Revised SPC: Insulin lispro; Insuman Infusat/Comb/Rapid (human insulin) and Toujeo (insulin glargine)

SPCs have been updated to advise insulin absorption may vary from one injection area to another (e.g. abdominal wall vs. thigh) and injection sites within an injection area must be rotated from one injection to next in order to reduce risk of lipodystrophy & cutaneous amyloidosis

Source:

electronic Medicines compendium